7). ABA triggers cell death by necrosis in a concentration- and time-dependent manner, becoming significant at 60 min for concentrations of 75 and 100 μM (Bottom panel). Fifty micromolar of ABA triggered necrosis after only 120 min of incubation. Proadifen LDK378 mouse stimulated the ABA-induced cell necrosis. In this study, we used isolated rat hepatocytes to study the toxicity mechanism induced by ABA in vitro and the influence of biotransformation of the drug. The interference of ABA in the functioning of the mitochondrial
respiratory chain in isolated rat hepatocytes was monitored by measuring oxygen consumption. The results showed a clear inhibition of the rate of oxygen consumption in state 3 of mitochondrial respiration with both substrates of complex I (glutamate + malate) and complex II (succinate) at all of the tested concentrations (5–25 μM). These results are consistent with those obtained by Castanha Zanoli et al. (2012), in which the effects of ABA on the isolated mitochondria of rat liver were evaluated and an inhibitory effect on the ANT and FoF1-ATPsintase
was shown. During the biotransformation of xenobiotics in the liver, BTK inhibitor the metabolites generated can be even more toxic than the parent compound (Ioannides and Lewis, 2004). In a study using rat liver microsomes, Zeng et al. (1996) showed that the major metabolites produced from abamectin are 3″-O-Desmethyl B1a (3″-ODMe B1a), 24-Hydroxymethyl B1a (24 OHMe-B1a) and 26-Hydroxymethyl B1a (26 OHMe-B1a). The authors attributed the metabolism of ABA to cytochrome P450 isoforms 1A1 and 3A as responsible for the metabolism of ABA, being the production of the metabolite 3″-ODMe B1a attributed to isoform 3A and the production of metabolites 24 OHMe-B1a and 26-OHMe B1a to isoform 1A1. Therefore, to evaluate the effect of the biotransformation on ABA toxicity, the hepatocytes were incubated in the absence or presence of proadifen, a broad inhibitor
of cytochrome P450 isoforms (Khan et al., 1993, Bort et al., 1998, Mingatto et al., 2002, Somchit et al., 2009 and Shi et al., 2011), which was previously shown to inhibit about 90% of the metabolism of ABA (Zeng et al., 1996). ABA metabolism else interferes with the mitochondrial membrane potential because a more significant decrease in this parameter was observed in hepatocytes in the presence of proadifen. Due to the inhibition of oxidative phosphorylation and the formation of a mitochondrial membrane potential induced by ABA, a reduction in the intracellular ATP concentration is expected. This effect was observed in liver cells incubated with or without proadifen. The effect was more pronounced in the cells incubated with the P450 inhibitor, indicating that the parent drug is more toxic than the metabolites. Castanha Zanoli et al.